Steris (STE) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.
Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.Sale Julia Madsen, Sr. Vp And Gm, Life Sciences sold 2,046 shares at $260.00 ($532K).
- Trade date
- Nov 13, 2026
- Disclosed to the SEC
- Nov 17, 2026
- Type
- Sale (code S)
Read the original SEC filing ↗All STE insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
STE insider transactions (Form 4)
Open-market purchases and sales. 54 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Nov 17SEC | Julia MadsenSr. Vp And Gm, Life Sciences | Sell | 2,04610,211 held (−17%) | $260.00 | $532K | -1.9% | — |
| Nov 12SEC | Karen L. BurtonCFO | Sell | 5,88012,956 held (−31%) | $255.62 | $1.5M | -0.3% | — |
| Nov 12SEC | Mohsen SohiDirector | Sell | 3,22825,970 held (−11%) | $252.87 | $816K | +0.8% | — |
| Nov 12SEC | Mohsen SohiDirector | Sell | 1,66524,305 held (−6%) | $253.90 | $423K | +0.4% | — |
| Aug 12SEC | Mohsen SohiDirector | Sell | 4,05824,305 held (−14%) | $235.78 | $957K | +8.1% | — |
| Jun 16SEC | John Adam ZangerleSr. Vp, Gen Counsel, And Sec. | Sell Plan | 1,41935,259 held (−4%) | $209.28 | $297K | +21.8% | — |
| Jun 8SEC | Daniel A. CarestioCEO, President | Sell Plan | 3,05465,021 held (−4%) | $214.64 | $656K | +18.8% | — |
| Jun 8SEC | Daniel A. CarestioCEO, President | Sell Plan | 1,37463,647 held (−2%) | $212.00 | $291K | +20.3% | — |
| Jun 4SEC | Richard C. BreedenDirector | Sell | 1,48138,964 held (−4%) | $209.51 | $310K | +21.7% | — |
| Mar 6SEC | Cynthia L. FeldmannDirector | Sell | 3,098705 held (−81%) | $237.21 | $735K | +7.5% | — |
| Nov 25SEC | Julia MadsenSr. Vp And Gm, Life Sciences | Sell | 2,87210,710 held (−21%) | $262.00 | $752K | -2.7% | — |
| Nov 25SEC | Julia MadsenSr. Vp And Gm, Life Sciences | Sell | 2,13610,710 held (−17%) | $262.00 | $560K | -2.7% | — |
| Nov 20SEC | Renato TamaroV.P. & Corporate Treasurer | Sell | 3,3247,407 held (−31%) | $257.43 | $856K | -1.0% | — |
| Nov 20SEC | Renato TamaroV.P. & Corporate Treasurer | Sell | 1,5005,695 held (−21%) | $257.76 | $387K | -1.1% | — |
| Nov 20SEC | Renato TamaroV.P. & Corporate Treasurer | Sell | 2127,195 held (−3%) | $258.03 | $55K | -1.2% | — |
| Nov 13SEC | John Adam ZangerleSr. Vp, Gen Counsel, And Sec. | Sell | 15,00033,669 held (−31%) | $265.14 | $4.0M | -3.8% | — |
| Oct 8SEC | Daniel A. CarestioCEO, President | Sell Plan | 15951,096 held (−0%) | $241.82 | $38K | +5.4% | — |
Similar past setups: not applicable. STE has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with STE in the Research Lab
STE has no open-market insider buys in the last 12 months. Try the tools with any setup.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Steris insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 8 sold $9.1M of STE stock on the open market; P/E 32.1 vs. a sector median of 25.0.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
STE insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $3.3M | 4 |
| Q3 2026 | — | 0 | $957K | 1 |
| Q2 2026 | — | 0 | $1.6M | 4 |
| Q1 2026 | — | 0 | $735K | 1 |
| Q4 2025 | — | 0 | $6.6M | 7 |
Valuation, profit and volume
Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 0 Steris insiders reported open-market purchases totaling $0, while 8 insiders reported sales totaling $9.1M. 4 of 17 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
STE earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Aug 5, 2026 | +8.6% | None | -0.5%S&P -0.4% | -2.8% |
| May 11, 2026 | -7.2% | None | +1.6%S&P +0.1% | -1.4% |
| Feb 4, 2026 | -2.6% | None | -6.8%S&P -1.7% | -5.2% |
| Nov 5, 2025 | -0.2% | Sold $38K | +7.5%S&P -0.7% | +1.2% |
| Aug 6, 2025 | +0.5% | None | +5.5%S&P +0.7% | +4.1% |
| May 14, 2025 | +2.6% | None | +6.8%S&P +0.6% | -2.0% |
| Feb 5, 2025 | +4.7% | None | +2.8%S&P +0.8% | +3.5% |
| Nov 6, 2024 | +1.4% | None | -5.2%S&P +3.3% | +0.4% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
STE short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded STE
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Kevin HernHouse · R-OK | Sold $15,001 - $50,000 | Sep 15, 2026 | Sep 25, 2026 | +21.2% |
| April McClain DelaneyHouse | Sold $100,001 - $250,000 | Aug 25, 2026 | Sep 9, 2026 | +8.2% |
| Jared MoskowitzHouse · D-FL | Sold $1,001 - $15,000 | Jul 13, 2026 | Aug 27, 2026 | +17.8% |
| April McClain DelaneyHouse | Sold $1,001 - $15,000 | Jul 31, 2026 | Aug 3, 2026 | +12.0% |
| April McClain DelaneyHouse | Sold $1,001 - $15,000 | Jul 29, 2026 | Aug 3, 2026 | +8.9% |
| April McClain DelaneyHouse | Sold $1,001 - $15,000 | Jul 27, 2026 | Aug 3, 2026 | +17.1% |
| April McClain DelaneyHouse | Sold $1,001 - $15,000 | Jul 24, 2026 | Aug 3, 2026 | +19.5% |
| Gilbert Ray Cisneros, Jr.House · D-CA | Bought $1,001 - $15,000 | May 13, 2026 | Jun 8, 2026 | +21.5% |
| Gilbert Ray Cisneros, Jr.House · D-CA | Bought $1,001 - $15,000 | May 11, 2026 | Jun 8, 2026 | +27.1% |
| Gilbert Ray Cisneros, Jr.House · D-CA | Bought $1,001 - $15,000 | May 1, 2026 | May 8, 2026 | +19.6% |
| Gilbert Ray Cisneros, Jr.House · D-CA | Bought $1,001 - $15,000 | Apr 29, 2026 | May 8, 2026 | +20.6% |
| April McClain DelaneyHouse | Bought $1,001 - $15,000 | Apr 30, 2026 | May 6, 2026 | +18.3% |
Insiders at Steris
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| John Adam ZangerleSr. Vp, Gen Counsel, And Sec. | — | $4.3M | Jun 16, 2026 | — | — |
| Mohsen SohiDirector | — | $2.2M | Nov 12, 2026 | — | — |
| Julia MadsenSr. Vp And Gm, Life Sciences | — | $1.8M | Nov 17, 2026 | — | — |
| Karen L. BurtonCFO | — | $1.5M | Nov 12, 2026 | — | — |
| Renato TamaroV.P. & Corporate Treasurer | — | $1.3M | Jun 8, 2026 | — | — |
| Daniel A. CarestioCEO, President | — | $985K | Jun 8, 2026 | — | — |
| Cynthia L. FeldmannDirector | — | $735K | Mar 6, 2026 | — | — |
| Richard C. BreedenDirector | — | $310K | Jun 4, 2026 | — | — |
| Mary Clare FraserSvp & Chief Hro | — | — | Jun 8, 2026 | — | — |
| Kenneth E. KohlerSvp & Gm, Ast | — | — | Jun 8, 2026 | — | — |
| Lindsey McGowanVp, Chf. Comp. & Quality Offc. | — | — | Jun 4, 2026 | — | — |
| Cary L. MajorsPresident | — | — | Jun 4, 2026 | — | — |
Board links: companies that share insiders with STE
Directors and executives who filed Form 4s for STE and another company in the last 12 months.
- BKRBaker Hughes Mohsen Sohi Director here · Director at BKR · latest filing Nov 12, 2026
- UFPTUfp Technologies Cynthia L. Feldmann Director here · Director at UFPT · latest filing Aug 17, 2026
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
STE stock: common questions
Are Steris insiders buying STE stock?
No. No Steris insider reported an open-market purchase of STE in the past 12 months.
Are Steris insiders selling STE stock?
8 insiders reported sales worth $9.1M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is STE's P/E ratio?
STE trades at about 32.1 times trailing earnings, compared with a median of 25.0 for the Health Care sector.
What is STE's 52-week range?
Over the past year STE has traded between $198.79 and $266.36. It last closed at $254.94 on Nov 19, 2026.